{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:22:12Z","timestamp":1795018932466,"version":"4.10.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,11,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Vitiligo affects 0.5\u20132% of the global population and carries a substantial psychosocial burden. Topical ruxolitinib 1.5% cream is approved for nonsegmental vitiligo based on phase III trial data, but real-world evidence across heterogeneous populations remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the real-world effectiveness, safety and patient-reported outcomes of topical ruxolitinib across 34 Italian dermatology centres, and to identify possible clinical predictors of treatment response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Multicentre retrospective cohort study (July 2024\u2013October 2025). Patients (\u2265 12\u2005years of age) with nonsegmental vitiligo received ruxolitinib 1.5% cream twice daily. Primary outcomes were \u2265 75% improvement in Facial Vitiligo Area Scoring Index (F-VASI 75) 75 and \u2265 90% improvement in F-VASI (F-VASI 90) at 24 and 52 weeks. Secondary outcomes were Vitiligo Noticeability Scale, Dermatology Life Quality Index (DLQI), the vitiligo-specific quality-of-life instrument (VitiQoL), Generalized Anxiety Disorder 7-item scale (GAD-7) and Patient Health Questionnaire-9 (PHQ-9).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total, 860 patients (mean age 47\u2005years; 58% female sex; disease duration 13.5\u2005years; 84% previously treated) completed a 24-week assessment; 229 (26.6%) had reached 52 weeks at the time of data lock. F-VASI 75 was achieved by 18.5% at 24 weeks, increasing to 38.4% at 52 weeks; F-VASI 90 rose from 5.7% to 25.8%. In multivariable logistic regression, summer treatment initiation [adjusted odds ratio (OR) 6.7, 95% confidence interval (CI) 2.7\u201316.8] and Koebner phenomenon (adjusted OR 1.6, 95% CI 1.04\u20132.66) were independent predictors of F-VASI 75 at 24 weeks. At baseline, 37% of patients had moderate-to-severe anxiety (GAD-7 \u2265 10); this fell to 11% at 24 weeks and 2% at 52 weeks. VitiQoL, DLQI and PHQ-9 improved at all timepoints. Adverse events were mild in 99% of cases (86 of 87). The treatment discontinuation rate was 1.5%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In a large real-world population considerably more heterogeneous than registration-trial cohorts, topical ruxolitinib showed progressive repigmentation through 52 weeks with excellent tolerability. Summer initiation and Koebner phenomenon independently predicted early response, findings that may inform patient counselling and the design of prospective studies. The parallel sustained reduction in anxiety and depression supports the use of standardized mental health assessment as a routine component of vitiligo care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/bjd\/ljag342","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:23:31Z","timestamp":1786706611000},"page":"1030-1041","source":"Crossref","is-referenced-by-count":4,"title":["Real-world effectiveness of topical ruxolitinib in nonsegmental vitiligo: repigmentation, mental health and quality-of-life outcomes in an 860-patient multicentre study"],"prefix":"10.1093","volume":"195","author":[{"given":"Angelo V","family":"Marzano","sequence":"first","affiliation":[{"name":"Dermatology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico , Milan ,","place":["Italy"]},{"name":"Department of Pathophysiology and Transplantation, Universit\u00e0 degli Studi di Milano , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Narcisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8901-318X","authenticated-orcid":false,"given":"Gianluca","family":"Tavoletti","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa C","family":"Rossi","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Romagnuolo","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Amerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edvige","family":"Morea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Provenzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Rongioletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8221-6694","authenticated-orcid":false,"given":"Stefania","family":"Guida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1746-2708","authenticated-orcid":false,"given":"Lorenzo M","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"D\u2019Amore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Concetta","family":"Fargnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Pacifico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Iacovelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Rubegni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8301-9206","authenticated-orcid":false,"given":"Emanuele","family":"Trovato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Romanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Michelucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Micali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L","family":"Musumeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo L","family":"Di Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Coronella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Foti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucrezia","family":"Pacetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Giacalone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina B","family":"Spigariolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Nazzaro","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico , Milan ,","place":["Italy"]},{"name":"Department of Pathophysiology and Transplantation, Universit\u00e0 degli Studi di Milano , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Ribero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Mastorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Belloni Fortina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvise","family":"Sernicola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriana","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Matteucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eustachio","family":"Nettis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7919-8141","authenticated-orcid":false,"given":"Luca","family":"Stingeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Pellacani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annunziata","family":"Dattola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Zalaudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele D","family":"Caposiena Caro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiliano","family":"Antiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E","family":"Baffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4773-6993","authenticated-orcid":false,"given":"Maria","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfredo","family":"Bruni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Sena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Vezzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Cozzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Gasparini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1704-6799","authenticated-orcid":false,"given":"Niccol\u00f2","family":"Capurro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Savoia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiacomo","family":"Calzavara-Pinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariachiara","family":"Arisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasini","family":"Carlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Michelerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Barruscotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4899-6639","authenticated-orcid":false,"given":"Mauro","family":"Picardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Paganelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiorgio","family":"Malagoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Pileri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Giuffrida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santo R","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria G","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Argenziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Fulgione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampiero","family":"Girolomoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Maurelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Costanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Cartocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketty","family":"Peris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7163-1035","authenticated-orcid":false,"given":"Silvia","family":"Alberti-Violetti","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico , Milan ,","place":["Italy"]},{"name":"Department of Pathophysiology and Transplantation, Universit\u00e0 degli Studi di Milano , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"2026111810525614400_ljag342-B1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","article-title":"Vitiligo","volume":"386","author":"Ezzedine","year":"2015","journal-title":"Lancet"},{"key":"2026111810525614400_ljag342-B2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s40257-021-00631-6","article-title":"Psychosocial effects of vitiligo: a systematic literature review","volume":"22","author":"Ezzedine","year":"2021","journal-title":"Am J Clin Dermatol"},{"key":"2026111810525614400_ljag342-B3","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/jamadermatol.2023.2787","article-title":"Mental health and psychosocial quality-of-life burden among patients with vitiligo: findings from the Global VALIANT Study","volume":"159","author":"Bibeau","year":"2023","journal-title":"JAMA Dermatol"},{"key":"2026111810525614400_ljag342-B4","first-page":"CD003263","article-title":"Interventions for vitiligo","volume":"2015","author":"Whitton","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2026111810525614400_ljag342-B5","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/jid.2011.463","article-title":"A mouse model of vitiligo with focused epidermal depigmentation requires IFN-\u03b3 for autoreactive CD8+ T-cell accumulation in the skin","volume":"132","author":"Harris","year":"2012","journal-title":"J Invest Dermatol"},{"key":"2026111810525614400_ljag342-B6","doi-asserted-by":"crossref","first-page":"223ra23","DOI":"10.1126\/scitranslmed.3007811","article-title":"CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo","volume":"6","author":"Rashighi","year":"2014","journal-title":"Sci Transl Med"},{"key":"2026111810525614400_ljag342-B7","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1038\/jid.2015.335","article-title":"Transcriptional analysis of vitiligo skin reveals the alteration of WNT pathway: a promising target for repigmenting vitiligo patients","volume":"135","author":"Regazzetti","year":"2015","journal-title":"J Invest Dermatol"},{"key":"2026111810525614400_ljag342-B8","author":"US Food and Drug Administration"},{"key":"2026111810525614400_ljag342-B9","author":"Agenzia Italiana del Farmaco (AIFA)"},{"key":"2026111810525614400_ljag342-B10","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa2118828","article-title":"Two phase 3 randomized controlled trials of ruxolitinib cream for vitiligo","volume":"387","author":"Rosmarin","year":"2022","journal-title":"N Engl J Med"},{"key":"2026111810525614400_ljag342-B11","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/ijd.70240","article-title":"Real-life perception of treatment effectiveness after 24 weeks of topical ruxolitinib in non-segmental vitiligo: insights from patient-reported outcomes","volume":"65","author":"Alberti-Violetti","year":"2026","journal-title":"Int J Dermatol"},{"key":"2026111810525614400_ljag342-B12","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1111\/ijd.17998","article-title":"The impact of vitiligo on patients\u2019 quality of life: retrospective observational study","volume":"64","author":"Picone","year":"2025","journal-title":"Int J Dermatol"},{"key":"2026111810525614400_ljag342-B13","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/ijd.70049","article-title":"Effectiveness and safety of ruxolitinib cream 15\u2005mg\/g in patients with non-segmental vitiligo: a real-life study","volume":"65","author":"Cristallo","year":"2026","journal-title":"Int J Dermatol"},{"key":"2026111810525614400_ljag342-B14","first-page":"574","article-title":"Evaluation of the safety and efficacy of ruxolitinib cream in the treatment of vitiligo- a comparative observational study","volume":"7","author":"Sarker","year":"2024","journal-title":"Fortune J Health Scis"},{"key":"2026111810525614400_ljag342-B15","first-page":"e78247","article-title":"Real-world use of topical ruxolitinib in vitiligo: retrospective cross-sectional mixed methods infodemiology study of the r\/vitiligo subreddit","volume":"27","author":"Kirchberger","year":"2025","journal-title":"J Med Int Res"},{"key":"2026111810525614400_ljag342-B16","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1111\/jdv.19451","article-title":"Worldwide expert recommendations for the diagnosis and management of vitiligo: position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm","volume":"37","author":"van Geel","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026111810525614400_ljag342-B17","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"2026111810525614400_ljag342-B18","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"2026111810525614400_ljag342-B19","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jad.2020.01.032","article-title":"Sensitivity to change and minimal clinically important difference of the 7-item Generalized Anxiety Disorder Questionnaire (GAD-7)","volume":"265","author":"Toussaint","year":"2020","journal-title":"J Affect Disord"},{"key":"2026111810525614400_ljag342-B20","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/bjd.14208","article-title":"Validation of the Vitiligo Noticeability Scale: a patient-reported outcome measure of vitiligo treatment success","volume":"174","author":"Batchelor","year":"2016","journal-title":"Br J Dermatol"},{"key":"2026111810525614400_ljag342-B21","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s13555-025-01381-7","article-title":"Efficacy and safety of ruxolitinib cream in vitiligo by patient characteristics subgroups: descriptive pooled analysis from two phase 3 studies","volume":"15","author":"Seneschal","year":"2025","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2026111810525614400_ljag342-B22","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/bjd\/ljaf485","article-title":"Open-label treatment extension of ruxolitinib cream in vitiligo: findings from the Topical Ruxolitinib Evaluation in Vitiligo (TRuE-V) long-term extension phase III study","volume":"194","author":"Harris","year":"2026","journal-title":"Br J Dermatol"},{"key":"2026111810525614400_ljag342-B23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/0974-2077.112667","article-title":"Stability in vitiligo: is there a perfect way to predict it?","volume":"6","author":"Sahni","year":"2013","journal-title":"J Cutan Aesthet Surg"},{"key":"2026111810525614400_ljag342-B24","doi-asserted-by":"crossref","first-page":"111779","DOI":"10.1016\/j.mad.2023.111779","article-title":"Acceleration of melanocyte senescence by the proinflammatory cytokines IFN\u03b3 and TNF\u03b1 impairs the repigmentation response of vitiligo patients to narrowband UVB (nUVB) phototherapy","volume":"211","author":"Dong","year":"2023","journal-title":"Mech Ageing Dev"},{"key":"2026111810525614400_ljag342-B25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1034\/j.1600-0749.2002.1o049.x","article-title":"New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions","volume":"15","author":"Moretti","year":"2002","journal-title":"Pigment Cell Res"},{"key":"2026111810525614400_ljag342-B26","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/med.21426","article-title":"Trends in regenerative medicine: repigmentation in vitiligo through melanocyte stem cell mobilization","volume":"37","author":"Birlea","year":"2017","journal-title":"Med Res Rev"},{"key":"2026111810525614400_ljag342-B27","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/j.jid.2025.11.016","article-title":"Efficacy and safety of ruxolitinib cream combined with narrow-band UVB phototherapy for treatment of vitiligo","volume":"146","author":"Pandya","year":"2026","journal-title":"J Invest Dermatol"},{"key":"2026111810525614400_ljag342-B28","doi-asserted-by":"crossref","first-page":"s752","DOI":"10.25251\/bpnxm492","article-title":"Characterizing deep quality-of-life response in the TRuE-V1\/TRuE-V2 studies of ruxolitinib cream in nonsegmental vitiligo","volume":"10","author":"Desai","year":"2026","journal-title":"SKIN: J Cutan Med"},{"key":"2026111810525614400_ljag342-B29","doi-asserted-by":"crossref","first-page":"388","DOI":"10.36849\/JDD.9696","article-title":"Association between topical ruxolitinib treatment and psychiatric outcomes in adults with vitiligo","volume":"25","author":"Sidhu","year":"2026","journal-title":"J Drugs Dermatol"},{"key":"2026111810525614400_ljag342-B30","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1007\/s13555-025-01555-3","article-title":"Long-term integrated safety summary of ruxolitinib cream in phase 3 clinical trials of patients with vitiligo","volume":"15","author":"Rosmarin","year":"2025","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2026111810525614400_ljag342-B31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/bjd\/ljad331","article-title":"Roadmap to VIRTUAL-GLOBAL: coordinating VItiligo RegisTries for adUlts And chiLdren internationally","volume":"190","author":"Eleftheriadou","year":"2024","journal-title":"Br J Dermatol"},{"key":"2026111810525614400_ljag342-B32","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/pcmr.12354","article-title":"Developing core outcome set for vitiligo clinical trials: international e-Delphi consensus","volume":"28","author":"Eleftheriadou","year":"2015","journal-title":"Pigment Cell Melanoma Res"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljag342\/70658086\/ljag342.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/195\/6\/1030\/70658086\/ljag342.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/195\/6\/1030\/70658086\/ljag342.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T15:53:08Z","timestamp":1795017188000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/195\/6\/1030\/8762036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,8,17]]},"published-print":{"date-parts":[[2026,11,18]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljag342","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,12]]},"published":{"date-parts":[[2026,8,17]]}}}